This broadcast features a multidisciplinary panel that will discuss the clinical and practical application of a once-daily GLP-1 RA. Through case-based discussions, they will explore initiating GLP-1 RA therapy early in the T2D treatment journey when metformin is no longer enough for glycemic control, patient communication, and the ways to coordinate optimal treatment from the perspective of a healthcare team.
Don’t miss your chance to be a part of this exclusive National Broadcast Event happening at select locations across the country. A Q&A session will follow the presentation.
This broadcast is intended for US healthcare practitioners involved in the treatment of T2D.
The broadcast will be available at various times throughout the day and evening, depending on your time zone. Refer to the chart below for a complete list of broadcast times.
Thursday, October 14, 2021
|12:15 PM||11:15 AM||10:15 AM||9:15 AM|
|1:15 PM||12:15 PM||11:15 AM||10:15 AM|
|3:15 PM||2:15 PM||1:15 PM||12:15 PM|
|7:00 PM||6:00 PM||5:00 PM||4:00 PM|
|8:30 PM||7:30 PM||6:30 PM||5:30 PM|
|10:00 PM||9:00 PM||8:00 PM||7:00 PM|